Abstract:α-synuclein (α-syn) is a 140-amino acid intrinsically disordered protein (IDP) and the primary component of cytotoxic oligomers implicated in the etiology of Parkinson's disease (PD). While IDPs lack a stable three-dimensional structure they sample a heterogeneous ensemble of conformations that can, in principle, be assessed through molecular dynamics simulations. However, describing the structure and aggregation of large IDPs is challenging due to force field (FF) accuracy and sampling limitations. To cope with the latter, coarse-grained (CG) FFs emerge as a potential alternative at the expense of atomic detail loss. Whereas CG models can accurately describe the structure of the monomer, less is known about aggregation. The latter is key for assessing aggregation pathways and designing aggregation inhibitor drugs. Herein, we investigate the structure and dynamics of α-syn using different resolution CG (Martini3 and Sirah2) and all-atom (Amber99sb and Charmm36m) FFs, to gain insight into the differences and resemblances between these models. The dependence of the magnitude of protein-water interactions and the putative need of enhanced sampling (replica-exchange) methods, in CG simulations, are analyzed to distinguish between force field accuracy and sampling limitations. The stability of the CG models of an α-syn fibril was also investigated. Additionally, α-syn aggregation was studied through umbrella sampling for the CG models and CG/all-atom models for an 11-mer peptide (NACore) from an amyloidogenic domain of α-syn. Our results show that despite the α-syn structures of Martini3 and Sirah2, with enhanced protein-water interactions, are similar, major differences exist concerning aggregation. The Martini3 fibril is not stable, and the binding free energy of α-syn and NACore is positive, opposite to Sirah2. Sirah2 peptides in a zwitterionic form, in turn, display too strong termini interactions, resulting in end-to-end orientation. Sirah2 with enhanced protein-water interactions and neutral termini provides, however, a peptide aggregation free energy profile similar to that found with all-atom models. Overall, we find that Sirah2 with enhanced protein-water interactions is suitable for studying protein-protein and protein-drug aggregation.

Wide-Line NMR Melting Diagrams, Their Thermodynamic Interpretation, and Secondary Structure Predictions for A30P and E46K α-Synuclein.

Differentially heterogeneous hydration environment of the familial mutants of α-synuclein

In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease

Molecular Insights into the Misfolding and Dimerization Dynamics of the Full-Length Α-Synuclein from Atomistic Discrete Molecular Dynamics Simulations.

Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy

Transient Beta-Hairpin Formation In Alpha-Synuclein Monomer Revealed By Coarse-Grained Molecular Dynamics Simulation

3,4‐Dihydroxyphenylethanol and 3,4‐dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α‐synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect

Familial Mutations May Switch Conformational Preferences in Α-Synuclein Fibrils.

Wild Type α-Synuclein Structure and Aggregation: A Comprehensive Coarse-Grained and All-Atom Molecular Dynamics Study

Coupling of the Non-Amyloid-component (NAC) Domain and the KTK(E/Q)GV Repeats Stabilize the Α-Synuclein Fibrils.

Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy

Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a novel fibril structure

Conformational equilibria in monomeric alpha-synuclein at the single molecule level

Exploring Structural Insights of Aβ42 and α-Synuclein Monomers and Heterodimer: A Comparative Study Using Implicit and Explicit Solvent Simulations

Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis

The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein

Structural and functional insights into nuclear role of Parkinson′s Disease-associated α-Synuclein

Divergent effects of pathological α-synuclein truncations and mutations on phase separation

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease

Characterization of the Non-Fibrillar alpha-Synuclein Oligomers

Label-free Detection of Early Oligomerization of Α-Synuclein and Its Mutants A30P/E46K Through Solid-State Nanopores.